Your browser doesn't support javascript.
loading
Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status.
Zetterlund, L; Celebioglu, F; Hatschek, T; Frisell, J; de Boniface, J.
Afiliación
  • Zetterlund L; Department of Clinical Science and Education, Karolinska Institutet, Southern General Hospital Stockholm, Sweden.
  • Celebioglu F; Department of Surgery, Breast Unit, Capio St Göran's Hospital, Stockholm, Sweden.
  • Hatschek T; Department of Clinical Science and Education, Karolinska Institutet, Southern General Hospital Stockholm, Sweden.
  • Frisell J; Department of Surgery, Southern General Hospital, Stockholm, Sweden.
  • de Boniface J; Department of Oncology and Pathology, Cancer Centre Karolinska, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Br J Surg ; 108(5): 583-589, 2021 05 27.
Article en En | MEDLINE | ID: mdl-34043772

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasia Residual Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Br J Surg Año: 2021 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasia Residual Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Br J Surg Año: 2021 Tipo del documento: Article País de afiliación: Suecia